Referred to the House Committee on Rules.
This resolution changes the internal rules of the House of Representatives to create a new standing Committee on Health and to adjust other committees' jurisdictions. It assigns topics like biomedical research, the Food and Drug Administration, public health, quarantine, and general-revenue supported health care to that new committee. Because it is a House simple resolution, it only governs House procedure and organization and does not create or change federal law affecting the public. It does not require Senate approval or the President's signature.
This is a simple House resolution considered and decided only by the House of Representatives; it is not sent to the Senate or the President. It changes House rules and committee structure but does not have the force of law outside House proceedings.
The resolution amends House rules to create a standing Committee on Health with jurisdiction over biomedical R&D (including FDA), health care funded by general revenues (excluding veterans), and public health/quarantine (including CDC).
It makes conforming jurisdictional changes to the Committees on Education and the Workforce and Energy and Commerce, removing specified health-related subparagraphs from Energy and Commerce and clarifying Education and Workforce's jurisdiction (excluding health insurance programs).
Internal rule change could pass if House majority leadership supports it, but likely triggers intra-House negotiations and resistance from affected committees.
Relative to its intended legislative type, this bill functions as a concise House-rule amendment that clearly seeks to create a Committee on Health by modifying Rule X and reallocating jurisdictional text; it supplies the essential statutory-language changes but omits ancillary implementation, funding, and accountability detail.
Liberals fear partisan use and privatization; conservatives see reform opportunity.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberals fear partisan use and privatization; conservatives see reform opportunity.
Likely cautiously positive about a dedicated health committee if it strengthens public health, research, and equitable healthcare oversight.
However, wary that jurisdictional shifts could be used to advance deregulatory or privatizing agendas depending on committee control.
Views the change as a reasonable procedural reform to resolve jurisdictional confusion and focus expertise.
Wants assurance about costs, staff transitions, and avoiding duplication across committees.
Generally supportive if the new committee enables focused oversight, regulatory reform, and legislative efficiency.
Some conservatives may worry about adding House bureaucracy unless it advances market-friendly reforms.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Internal rule change could pass if House majority leadership supports it, but likely triggers intra-House negotiations and resistance from affected committees.
The bill has not accumulated any surfaced votes yet.
Liberals fear partisan use and privatization; conservatives see reform opportunity.
Internal rule change could pass if House majority leadership supports it, but likely triggers intra-House negotiations and resistance from…
Relative to its intended legislative type, this bill functions as a concise House-rule amendment that clearly seeks to create a Committee on Health by modifying Rule X and reallocating jurisdictional text; it supplies t…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.